- Q1. What is the business of Paras Healthcare?Paras Healthcare operates a chain of multi-specialty hospitals offering advanced medical services like cardiology, oncology, neurosciences, orthopaedics, and gastro sciences, primarily in Tier-II and Tier-III cities.
- Q2. Why is the company raising funds via IPO?The company is raising funds via IPO to repay debts, fund new hospital expansions, and meet general corporate purposes.
- Q3. What is the size of the issue and where will it list?The IPO size is around ₹400 crore (fresh issue) plus an offer-for-sale; shares will list on BSE and NSE.
- Q5. What are the potential upsides?Upsides include strong regional presence, scalable business model, expanding healthcare demand, and potential profitability improvement.
- Q6. How to apply for the IPO?Investors can apply for the IPO through ASBA-enabled bank accounts or UPI-based online platforms offered by brokers.
Paras Healthcare IPO: Price, Review, Detail
Upcoming
15 July 2026
0
Rating
Founded in 2006, Paras Healthcare operates a network of multi-specialty tertiary hospitals across North and East India, focusing on making advanced medical care accessible and affordable.
The company’s IPO aims to raise approximately ₹400 crore via a fresh issue along with an offer-for-sale component, providing investors an opportunity to participate in India’s growing healthcare sector.
The company was incorporated on December 21, 1987,The Managing Director is Dr. Dharminder Kumar Nagar (also a promoter), who has spearheaded the company’s expansion since its inception.
Paras Healthcare Limited delivers specialised tertiary medical care services—covering cardiac sciences, oncology, neurosciences, gastro sciences, orthopaedics and joint replacement—primarily in underserved Tier-II and Tier-III cities.
Subscription date to apply for Paras Healthcare TBA. Price band for the IPO is TBA.
Revenue, PAT, EBITDA
|
Year
|
2024
|
|---|---|
|
Networth
|
~ ₹ 338.50 Cr
|
|
Revenue
|
~ ₹ 1129.03 Cr
|
|
EBITDA
|
~ ₹ 154.41 Cr
|
|
PAT
|
~ ₹ -15.33 Cr
|
|
EBITDA Margin
|
~ 13.68%
|
|
PAT Margin
|
-1.36%
|
|
Face Value
|
Rs.01 per Equity Share
|
IPO Important Dates
|
#
|
Date
|
|---|---|
|
Open Date
|
TBA
|
|
Close Date
|
TBA
|
|
Anchor Investor Bidding
|
TBA
|
|
Allotment Date
|
TBA
|
|
Refunds& Demat Credit
|
TBA
|
|
Tentative Listing Date
|
TBA
|
Use Of Proceeds
|
Purpose
|
Amount
|
|---|---|
|
Working Capital Requirements
|
~ ₹ 82.04 Cr
|
|
Subsidiary acquisition
|
|
|
Borrowing prepayment/repayment
|
~ ₹ 217.96 Cr
|
|
General Corporate Purpose
|
Balance
|
Financial Data
|
#
|
2022
|
2023
|
2024
|
|---|---|---|---|
|
Revenue (₹ Cr)
|
₹ 779.9
|
₹ 917.9
|
₹ 1,129.0
|
|
PAT (₹ Cr)
|
₹ -14.8
|
₹ -42.8
|
₹ -15.3
|
|
Asset (₹ Cr)
|
₹ 963.5
|
₹ 1,293.1
|
₹ 1,477.7
|
|
Net Worth (₹ Cr)
|
₹ 73.1
|
₹ 30.1
|
₹ 338.5
|
IPO Grey Market Premium
|
Date
|
IPO Price
|
IPO GMP
|
Profit Per Lot
|
|---|---|---|---|
|
17-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
16-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
15-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
14-Jun
|
₹ –
|
₹ –
|
₹ –
|
|
13-Jun
|
₹ –
|
₹ –
|
₹ –
|
Promoters – Pre offer equity (Approx)
|
Promoters
|
% Shares
|
|---|---|
|
Dr. Dharminder Kumar Nagar
|
~75.32%
|
|
Commelina Ltd.
|
~24.68%
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
|
-
|
-
|
Lot Size details
|
Application Type
|
Lot Size
|
No. of Lot
|
No. of Shares
|
Investment Amount
|
|---|---|---|---|---|
|
Retail (Min)
|
–
|
1
|
–
|
₹ –
|
|
Retail (Max)
|
–
|
13
|
–
|
₹ –
|
|
HNI (Min)
|
–
|
14
|
–
|
₹ –
|
|
HNI (Max)
|
–
|
66
|
–
|
₹ –
|
|
Big HNI (Min)
|
–
|
67
|
–
|
₹ –
|
Key Performance Index (KPI)
|
ROE
|
00
|
|---|---|
|
ROCE
|
00
|
|
RoNW
|
00
|
